{"id":6878,"date":"2023-05-29T02:52:03","date_gmt":"2023-05-29T02:52:03","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=6878"},"modified":"2023-08-29T18:01:24","modified_gmt":"2023-08-29T18:01:24","slug":"radiopharm-receives-positive-early-cancer-treatment-feedback-fda","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=6878","title":{"rendered":"Radiopharm\u6536\u5230FDA\u5bf9\u65e9\u671f\u764c\u75c7\u6cbb\u7597\u7684\u79ef\u6781\u53cd\u9988"},"content":{"rendered":"<p>\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u5f00\u53d1\u5546Radiopharm Theranostics\uff08ASX: RAD\uff09\u6b63\u5728\u5e86\u795d\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u5c31\u5176\u62df\u5f00\u53d1\u7684\u8bca\u65ad\u548c\u6cbb\u7597\u7528\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u4e3e\u884c\u4e86\u79ef\u6781\u7684\u9996\u6b21\u4f1a\u8bae\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u79f0\u8fd9\u662f\u4e00\u4e2a\u91cd\u8981\u7684\u91cc\u7a0b\u7891\uff0cRadiopharm\u5df2\u7ecf\u6210\u529f\u5730\u4e0eFDA\u5c31\u5176F18-pivalate\uff08RAD 101\uff09\u7684\u7533\u8bf7\u8fdb\u884c\u4e86\u65b0\u836f\u9884\u5ba1\uff08IND\uff09\u4f1a\u8bae\u3002<\/p>\n<p>RAD 101\u662f\u4e00\u79cd\u72ec\u7279\u7684\u6210\u50cf\u5242\uff0c\u7531F18\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u548c\u7279\u620a\u9178\u916f\u7ec4\u6210\uff0c\u662f\u4e00\u79cd\u9488\u5bf9\u8102\u80aa\u9178\u5408\u6210\u9176\u7684\u5c0f\u5206\u5b50\u3002<\/p>\n<p>\u4f26\u6566\u5e1d\u56fd\u5b66\u9662\uff08Imperial College of London\uff09\u8fdb\u884c\u7684\u6d4b\u8bd5\u4eceRAD 101\u7684IIa\u671f\u6210\u50cf\u8bd5\u9a8c\u4e2d\u83b7\u5f97\u4e86\u79ef\u6781\u6570\u636e\u3002<\/p>\n<p>\u8fd9\u4e9b\u8bd5\u9a8c\u53d1\u73b0\uff0c\u6709\u8111\u8f6c\u79fb\u7684\u75c5\u4eba\u663e\u793a\u51fa\u660e\u663e\u7684\u80bf\u7624\u6444\u53d6\uff0c\u4e0e\u539f\u53d1\u80bf\u7624\u4e00\u81f4\u4e14\u72ec\u7acb\u4e8e\u539f\u53d1\u80bf\u7624\uff0c\u7a81\u51fa\u4e86\u4f7f\u7528\u7279\u620a\u9178\u76d0\u76d1\u6d4b\u8111\u8f6c\u79fb\u7684\u6f5c\u529b\u3002<\/p>\n<p>Radiopharm Theranostics\u516c\u53f8\u9996\u5e2d\u6267\u884c\u5b98\u517c\u603b\u7ecf\u7406Riccardo Canevari\u8bf4\uff0cDFA\u7684\u9996\u6b21\u4f1a\u8bae\u662f\u8be5\u516c\u53f8\u8fdb\u4e00\u6b65\u53d1\u5c55\u540e\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684IND\u7533\u8bf7\u7684\u4e00\u4e2a\u91cd\u8981\u91cc\u7a0b\u7891\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u73b0\u5728\u5c06\u63d0\u4ea4\u4e00\u4efdIND\u7533\u8bf7\uff0c\u57282023\u5e74\u7b2c\u4e09\u5b63\u5ea6\u542f\u52a8\u4e00\u9879\u591a\u4e2d\u5fc3\u6210\u50cf\u8111\u8f6c\u79fb\u8bd5\u9a8c\uff0c\u76ee\u7684\u662f\u5728\u5e74\u5e95\u524d\u7ed9\u7b2c\u4e00\u4e2a\u75c5\u4eba\u7528\u836f\u3002<\/p>\n<p>Canevari\u5148\u751f\u8bf4\uff1a&#8221;Pivalate\u4ee3\u8868\u4e86\u4e00\u7c7b\u65b0\u7684\u9776\u5411\u653e\u5c04\u6027\u836f\u7269\uff0cRAD 101\u6570\u636e\u663e\u793a\u5176\u5728\u8111\u8f6c\u79fb\u4e2d\u8868\u73b0\u975e\u5e38\u79ef\u6781\u3002&#8221;<\/p>\n<p>&#8220;\u8003\u8651\u5230\u7f8e\u56fd\u6bcf\u5e74\u7ea6\u670930\u4e07\u540d\u60a3\u8005\u88ab\u8bca\u65ad\u4e3a\u8111\u8f6c\u79fb\uff0c\u6211\u4eec\u6b63\u5728\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u63a5\u89e6\uff0c\u4ee5\u52a0\u5febRAD 101\u7684\u4e34\u5e8a\u5f00\u53d1\uff0c\u8fd9\u662f\u672a\u6ee1\u8db3\u7684\u9ad8\u5ea6\u533b\u7597\u9700\u6c42\u3002&#8221;<\/p>\n<h2>\u6fb3\u5927\u5229\u4e9a\u7684\u6cbb\u7597\u8ba1\u5212<\/h2>\n<p>2022\u5e74\u5e95\uff0cRadiopham\u5ba3\u5e03\u4e0e\u5168\u7403\u764c\u75c7\u62a4\u7406\u63d0\u4f9b\u5546GenesisCare\u8fdb\u884c\u6218\u7565\u7814\u7a76\u5408\u4f5c\uff0c\u4e3a\u60a3\u6709\u590d\u6742\u3001\u96be\u4ee5\u6cbb\u7597\u7684\u764c\u75c7\u7684\u6fb3\u5927\u5229\u4e9a\u4eba\u5f00\u53d1\u65b0\u578b\u653e\u5c04\u6027\u836f\u7269\u3002<\/p>\n<p>\u6839\u636e\u5408\u4f5c\u5173\u7cfb\uff0c\u4e24\u5bb6\u516c\u53f8\u5c06\u5728\u6fb3\u5927\u5229\u4e9a\u8fdb\u884c\u591a\u9879\u4e16\u754c\u9996\u521b\u76841\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u91cd\u70b9\u5173\u6ce8\u80bf\u7624\u5b66\u4e2d\u672a\u5f97\u5230\u6ee1\u8db3\u7684\u9ad8\u9700\u6c42\u9886\u57df\u3002<\/p>\n<p>\u4f5c\u4e3a\u5408\u4f5c\u7684\u4e00\u90e8\u5206\uff0cGenesisCare\u7684Contract Research Organisation\uff08CRO\uff09\u548cImaging Research Organisation\uff08IRO\uff09\u5df2\u7ecf\u83b7\u5f97\u4e86\u5728\u6fb3\u5927\u5229\u4e9a\u5b9e\u65bd\u4e09\u9879\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5408\u540c\uff0c\u6d89\u53caRadiopharm\u7684\u653e\u5c04\u6027\u836f\u7269\u7eb3\u7c73\u6297\u4f53\u7ec4\u5408\u3002<\/p>\n<h2>\u653e\u5c04\u6027\u836f\u7269\u7684\u5de5\u4f5c\u539f\u7406<\/h2>\n<p>\u8be5\u8fc7\u7a0b\u6d89\u53ca\u5c06\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u9644\u7740\u5728\u5c0f\u5206\u5b50\u6216\u6297\u4f53\u7b49\u9776\u5411\u5242\u4e0a\u3002<\/p>\n<p>\u60a3\u8005\u88ab\u7ed9\u4e88\u975e\u5e38\u5c11\u91cf\u7684\u5b89\u5168\u653e\u5c04\u6027\u836f\u7269\u6ce8\u5c04\u5230\u8840\u6d41\u4e2d\u3002<\/p>\n<p>\u8be5\u5236\u5242\u4e13\u95e8\u4e0e\u80bf\u7624\u7ec6\u80de\u7ed3\u5408\uff0c\u5e76\u5c06\u653e\u5c04\u6027\u6709\u6548\u8f7d\u8377\u9001\u5230\u80bf\u7624\u7ec6\u80de\u3002<\/p>\n<p>\u6709\u6548\u8f7d\u8377\u53ef\u7528\u4e8e\u8bca\u65ad\uff08\u901a\u8fc7\u6210\u50cf\uff09\u6216\u6cbb\u7597\u6216\u4e24\u8005\u517c\u800c\u6709\u4e4b\u3002<\/p>\n<p>\u5728\u6cbb\u7597\u6027\u5e94\u7528\u7684\u60c5\u51b5\u4e0b\uff0c\u5b83\u5141\u8bb8\u8be5\u673a\u5236\u5177\u6709\u6781\u9ad8\u7684\u9009\u62e9\u6027\uff0c\u4ee5\u7cbe\u786e\u5730\u63d0\u4f9b\u4e00\u79cd\u653e\u5c04\u6027\u836f\u7269\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u5f00\u53d1\u5546Radiopharm Theranostics\uff08ASX: RAD\uff09\u6b63\u5728\u5e86\u795d\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u5c31\u5176\u62df\u5f00\u53d1\u7684\u8bca\u65ad\u548c\u6cbb\u7597\u7528\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u4e3e\u884c\u4e86\u79ef\u6781\u7684\u9996\u6b21\u4f1a\u8bae\u3002 \u8be5\u516c\u53f8\u79f0\u8fd9\u662f\u4e00\u4e2a\u91cd\u8981\u7684\u91cc\u7a0b\u7891\uff0cRadiopharm\u5df2\u7ecf\u6210\u529f\u5730\u4e0eFDA\u5c31\u5176F18-pivalate\uff08RAD 101\uff09\u7684\u7533\u8bf7\u8fdb\u884c\u4e86\u65b0\u836f\u9884\u5ba1\uff08IND\uff09\u4f1a\u8bae\u3002 RAD 101\u662f\u4e00\u79cd\u72ec\u7279\u7684\u6210\u50cf\u5242\uff0c\u7531F18\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u548c\u7279\u620a\u9178\u916f\u7ec4\u6210\uff0c\u662f\u4e00\u79cd\u9488\u5bf9\u8102\u80aa\u9178\u5408\u6210\u9176\u7684\u5c0f\u5206\u5b50\u3002 \u4f26\u6566\u5e1d\u56fd\u5b66\u9662\uff08Imperial College of London\uff09\u8fdb\u884c\u7684\u6d4b\u8bd5\u4eceRAD 101\u7684IIa\u671f\u6210\u50cf\u8bd5\u9a8c\u4e2d\u83b7\u5f97\u4e86\u79ef\u6781\u6570\u636e\u3002 \u8fd9\u4e9b\u8bd5\u9a8c\u53d1\u73b0\uff0c\u6709\u8111\u8f6c\u79fb\u7684\u75c5\u4eba\u663e\u793a\u51fa\u660e\u663e\u7684\u80bf\u7624\u6444\u53d6\uff0c\u4e0e\u539f\u53d1\u80bf\u7624\u4e00\u81f4\u4e14\u72ec\u7acb\u4e8e\u539f\u53d1\u80bf\u7624\uff0c\u7a81\u51fa\u4e86\u4f7f\u7528\u7279\u620a\u9178\u76d0\u76d1\u6d4b\u8111\u8f6c\u79fb\u7684\u6f5c\u529b\u3002 Radiopharm Theranostics\u516c\u53f8\u9996\u5e2d\u6267\u884c\u5b98\u517c\u603b\u7ecf\u7406Riccardo Canevari\u8bf4\uff0cDFA\u7684\u9996\u6b21\u4f1a\u8bae\u662f\u8be5\u516c\u53f8\u8fdb\u4e00\u6b65\u53d1\u5c55\u540e\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684IND\u7533\u8bf7\u7684\u4e00\u4e2a\u91cd\u8981\u91cc\u7a0b\u7891\u3002 \u8be5\u516c\u53f8\u73b0\u5728\u5c06\u63d0\u4ea4\u4e00\u4efdIND\u7533\u8bf7\uff0c\u57282023\u5e74\u7b2c\u4e09\u5b63\u5ea6\u542f\u52a8\u4e00\u9879\u591a\u4e2d\u5fc3\u6210\u50cf\u8111\u8f6c\u79fb\u8bd5\u9a8c\uff0c\u76ee\u7684\u662f\u5728\u5e74\u5e95\u524d\u7ed9\u7b2c\u4e00\u4e2a\u75c5\u4eba\u7528\u836f\u3002 Canevari\u5148\u751f\u8bf4\uff1a&#8221;Pivalate\u4ee3\u8868\u4e86\u4e00\u7c7b\u65b0\u7684\u9776\u5411\u653e\u5c04\u6027\u836f\u7269\uff0cRAD 101\u6570\u636e\u663e\u793a\u5176\u5728\u8111\u8f6c\u79fb\u4e2d\u8868\u73b0\u975e\u5e38\u79ef\u6781\u3002&#8221; &#8220;\u8003\u8651\u5230\u7f8e\u56fd\u6bcf\u5e74\u7ea6\u670930\u4e07\u540d\u60a3\u8005\u88ab\u8bca\u65ad\u4e3a\u8111\u8f6c\u79fb\uff0c\u6211\u4eec\u6b63\u5728\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\u63a5\u89e6\uff0c\u4ee5\u52a0\u5febRAD 101\u7684\u4e34\u5e8a\u5f00\u53d1\uff0c\u8fd9\u662f\u672a\u6ee1\u8db3\u7684\u9ad8\u5ea6\u533b\u7597\u9700\u6c42\u3002&#8221; \u6fb3\u5927\u5229\u4e9a\u7684\u6cbb\u7597\u8ba1\u5212 2022\u5e74\u5e95\uff0cRadiopham\u5ba3\u5e03\u4e0e\u5168\u7403\u764c\u75c7\u62a4\u7406\u63d0\u4f9b\u5546GenesisCare\u8fdb\u884c\u6218\u7565\u7814\u7a76\u5408\u4f5c\uff0c\u4e3a\u60a3\u6709\u590d\u6742\u3001\u96be\u4ee5\u6cbb\u7597\u7684\u764c\u75c7\u7684\u6fb3\u5927\u5229\u4e9a\u4eba\u5f00\u53d1\u65b0\u578b\u653e\u5c04\u6027\u836f\u7269\u3002 \u6839\u636e\u5408\u4f5c\u5173\u7cfb\uff0c\u4e24\u5bb6\u516c\u53f8\u5c06\u5728\u6fb3\u5927\u5229\u4e9a\u8fdb\u884c\u591a\u9879\u4e16\u754c\u9996\u521b\u76841\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u91cd\u70b9\u5173\u6ce8\u80bf\u7624\u5b66\u4e2d\u672a\u5f97\u5230\u6ee1\u8db3\u7684\u9ad8\u9700\u6c42\u9886\u57df\u3002 \u4f5c\u4e3a\u5408\u4f5c\u7684\u4e00\u90e8\u5206\uff0cGenesisCare\u7684Contract Research Organisation\uff08CRO\uff09\u548cImaging Research Organisation\uff08IRO\uff09\u5df2\u7ecf\u83b7\u5f97\u4e86\u5728\u6fb3\u5927\u5229\u4e9a\u5b9e\u65bd\u4e09\u9879\u4e34\u5e8a\u8bd5\u9a8c\u7684\u5408\u540c\uff0c\u6d89\u53caRadiopharm\u7684\u653e\u5c04\u6027\u836f\u7269\u7eb3\u7c73\u6297\u4f53\u7ec4\u5408\u3002 \u653e\u5c04\u6027\u836f\u7269\u7684\u5de5\u4f5c\u539f\u7406 \u8be5\u8fc7\u7a0b\u6d89\u53ca\u5c06\u653e\u5c04\u6027\u540c\u4f4d\u7d20\u9644\u7740\u5728\u5c0f\u5206\u5b50\u6216\u6297\u4f53\u7b49\u9776\u5411\u5242\u4e0a\u3002 \u60a3\u8005\u88ab\u7ed9\u4e88\u975e\u5e38\u5c11\u91cf\u7684\u5b89\u5168\u653e\u5c04\u6027\u836f\u7269\u6ce8\u5c04\u5230\u8840\u6d41\u4e2d\u3002 \u8be5\u5236\u5242\u4e13\u95e8\u4e0e\u80bf\u7624\u7ec6\u80de\u7ed3\u5408\uff0c\u5e76\u5c06\u653e\u5c04\u6027\u6709\u6548\u8f7d\u8377\u9001\u5230\u80bf\u7624\u7ec6\u80de\u3002 \u6709\u6548\u8f7d\u8377\u53ef\u7528\u4e8e\u8bca\u65ad\uff08\u901a\u8fc7\u6210\u50cf\uff09\u6216\u6cbb\u7597\u6216\u4e24\u8005\u517c\u800c\u6709\u4e4b\u3002 \u5728\u6cbb\u7597\u6027\u5e94\u7528\u7684\u60c5\u51b5\u4e0b\uff0c\u5b83\u5141\u8bb8\u8be5\u673a\u5236\u5177\u6709\u6781\u9ad8\u7684\u9009\u62e9\u6027\uff0c\u4ee5\u7cbe\u786e\u5730\u63d0\u4f9b\u4e00\u79cd\u653e\u5c04\u6027\u836f\u7269\u3002<\/p>\n","protected":false},"author":5,"featured_media":18353,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[1315],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Radiopharm\u6536\u5230FDA\u5bf9\u65e9\u671f\u764c\u75c7\u6cbb\u7597\u7684\u79ef\u6781\u53cd\u9988<\/title>\n<meta name=\"description\" content=\"\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u5f00\u53d1\u5546Radiopharm Theranostics\uff08ASX: RAD\uff09\u6b63\u5728\u5e86\u795d\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u5c31\u5176\u62df\u5f00\u53d1\u7684\u8bca\u65ad\u548c\u6cbb\u7597\u7528\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u4e3e\u884c\u4e86\u79ef\u6781\u7684\u9996\u6b21\u4f1a\u8bae\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Radiopharm\u6536\u5230FDA\u5bf9\u65e9\u671f\u764c\u75c7\u6cbb\u7597\u7684\u79ef\u6781\u53cd\u9988\" \/>\n<meta property=\"og:description\" content=\"\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u5f00\u53d1\u5546Radiopharm Theranostics\uff08ASX: RAD\uff09\u6b63\u5728\u5e86\u795d\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u5c31\u5176\u62df\u5f00\u53d1\u7684\u8bca\u65ad\u548c\u6cbb\u7597\u7528\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u4e3e\u884c\u4e86\u79ef\u6781\u7684\u9996\u6b21\u4f1a\u8bae\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-29T02:52:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:01:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Radiopharm-Theranostics-ASX-RAD-FDA-radiopharmaceuticals-brain-metastases-cancer-treatment.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/\",\"name\":\"Radiopharm\u6536\u5230FDA\u5bf9\u65e9\u671f\u764c\u75c7\u6cbb\u7597\u7684\u79ef\u6781\u53cd\u9988\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2023-05-29T02:52:03+00:00\",\"dateModified\":\"2023-08-29T18:01:24+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u5f00\u53d1\u5546Radiopharm Theranostics\uff08ASX: RAD\uff09\u6b63\u5728\u5e86\u795d\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u5c31\u5176\u62df\u5f00\u53d1\u7684\u8bca\u65ad\u548c\u6cbb\u7597\u7528\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u4e3e\u884c\u4e86\u79ef\u6781\u7684\u9996\u6b21\u4f1a\u8bae\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Radiopharm\u6536\u5230FDA\u5bf9\u65e9\u671f\u764c\u75c7\u6cbb\u7597\u7684\u79ef\u6781\u53cd\u9988\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Radiopharm\u6536\u5230FDA\u5bf9\u65e9\u671f\u764c\u75c7\u6cbb\u7597\u7684\u79ef\u6781\u53cd\u9988","description":"\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u5f00\u53d1\u5546Radiopharm Theranostics\uff08ASX: RAD\uff09\u6b63\u5728\u5e86\u795d\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u5c31\u5176\u62df\u5f00\u53d1\u7684\u8bca\u65ad\u548c\u6cbb\u7597\u7528\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u4e3e\u884c\u4e86\u79ef\u6781\u7684\u9996\u6b21\u4f1a\u8bae\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Radiopharm\u6536\u5230FDA\u5bf9\u65e9\u671f\u764c\u75c7\u6cbb\u7597\u7684\u79ef\u6781\u53cd\u9988","og_description":"\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u5f00\u53d1\u5546Radiopharm Theranostics\uff08ASX: RAD\uff09\u6b63\u5728\u5e86\u795d\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u5c31\u5176\u62df\u5f00\u53d1\u7684\u8bca\u65ad\u548c\u6cbb\u7597\u7528\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u4e3e\u884c\u4e86\u79ef\u6781\u7684\u9996\u6b21\u4f1a\u8bae\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/","og_site_name":"smallcapsCN","article_published_time":"2023-05-29T02:52:03+00:00","article_modified_time":"2023-08-29T18:01:24+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Radiopharm-Theranostics-ASX-RAD-FDA-radiopharmaceuticals-brain-metastases-cancer-treatment.jpg","type":"image\/jpeg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/","url":"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/","name":"Radiopharm\u6536\u5230FDA\u5bf9\u65e9\u671f\u764c\u75c7\u6cbb\u7597\u7684\u79ef\u6781\u53cd\u9988","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2023-05-29T02:52:03+00:00","dateModified":"2023-08-29T18:01:24+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u5f00\u53d1\u5546Radiopharm Theranostics\uff08ASX: RAD\uff09\u6b63\u5728\u5e86\u795d\u4e0e\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u5c31\u5176\u62df\u5f00\u53d1\u7684\u8bca\u65ad\u548c\u6cbb\u7597\u7528\u653e\u5c04\u6027\u836f\u7269\u4ea7\u54c1\u4e3e\u884c\u4e86\u79ef\u6781\u7684\u9996\u6b21\u4f1a\u8bae\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/radiopharm-receives-positive-early-cancer-treatment-feedback-fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Radiopharm\u6536\u5230FDA\u5bf9\u65e9\u671f\u764c\u75c7\u6cbb\u7597\u7684\u79ef\u6781\u53cd\u9988"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6878"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6878"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6878\/revisions"}],"predecessor-version":[{"id":20676,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/6878\/revisions\/20676"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/18353"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}